MedPath

Online Stress Management and Coping Skills Training for Women With Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Interventions
Behavioral: Coping with Breast Cancer web-based workbook
Registration Number
NCT01335152
Lead Sponsor
Talaria, Inc
Brief Summary

Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer.

This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support.

The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.

Detailed Description

Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer.

This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support.

The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Diagnosis of stage 0, I, II or III breast cancer within past 18 months
  • Elevated stress, distress or negative mood
  • Access at least 1.5 - 2 hours per week to a computer with audio capabilities that is connected to the internet
  • Ability to read, write, and speak English at a sixth grade level
  • Access to a telephone and an active e-mail account
Exclusion Criteria
  • Cancer diagnosis is a recurrence
  • Diagnosis of schizophrenia
  • Use of anti-psychotic medication
  • Diagnosis of bipolar disorder without use of mood stabilizing medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Web-based workbookCoping with Breast Cancer web-based workbookParticipants will use one chapter of the web-based workbook each week for 10 weeks. The workbook consists of stress management education, cognitive behavioral interventions and relaxation training exercises.
Primary Outcome Measures
NameTimeMethod
PHQ GAD-7 - Anxietybaseline, post-intervention, follow-up

7-item self-report questionnaire measureing anxiety.

CES-D 10baseline, post-intervention, follow-up

10 item self-report measure of depression.

FACT-B: Functional Assessment of Cancer Therapy - Breastbaseline, post-intervention, follow-up

44 item self-report measure of health related quality of life for breast cancer patients.

Secondary Outcome Measures
NameTimeMethod
Revised Impact of Event Scalebaseline, post-intervention, follow-up

22 item self-report measure of intrusive thoughts and avoidance of cancer-related thoughts.

Benefit Finding Scale for breast cancerbaseline, post-intervention, follow-up

17-item self-report measure of finding positive impact of negative events.

CANCER BEHAVIOR INVENTORY (CBI-B)baseline, post-intervention, follow-up

16-item self-report measure of self-efficacy for coping with cancer and cancer treatment.

Trial Locations

Locations (1)

Talaria, Inc

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath